Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in caucasian patients

Journal of Clinical Investigation

Volumn 100, Issue 4, 1997, Pages 814-820

  Pei, York ^a,b   Scholey, James ^a   Thai, Kerri ^a   Suzuki, Miyo ^a   Cattran, Daniel ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Genetic association; IgA nephropathy; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CREATININE CLEARANCE; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0344531802     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119596     Document Type: Article

References (42)

1. D'Amico, G., L. Minetti, C. Ponticelli, G. Fellin, F. Ferrario, G. Barbiano Di Belgioioso, E. Imbasciati, A. Ragni, S. Bertoli, G. Fogazzi, and G. Duca. 1986. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q. J. Med. 59:363-378.
2. Alamartine, E., J. Sabatier, C. Guerin, J. Berliet, and F. Berthoux. 1991. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am. J. Kidney Dis. 18:12-19.
3. Coppo, R., A. Amore, B. Gianoglio, G. Cacace, G. Picciotto, D. Roccatello, L. Peruzzi, G. Piccoli, and P. Filippi. 1993. Angiotensin II local hyperreactivity in the progression of IgA nephropathy. Am. J. Kidney Dis. 21:593-602.
4. Remuzzi, A., E. Perticucci, P. Ruggenenti, L. Mosconi, M. Limonta, and G. Remuzzi. 1991. Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int. 39:1267-1273.
5. Rekola, S., A. Bergstrand, and H. Bucht. 1991. Deterioration rate in IgA nephropathy: comparison of a converting enzyme-inhibitor and β-blocking agents. Nephron. 59:57-60.
6. Cattran, D., C. Greenwood, and S. Ritchie. 1994. Long-term benefit of angiotensin enzyme inhibitor therapy in patients with severe IgA nephropathy: comparison to patients receiving other antihypertensive agents and to patients receiving no therapy. Am. J. Kidney Dis. 23:247-252.
7. Jeunemaitre, X., F. Soubrier, Y. Kotelevtsev, R. Lifton, C. Williams, A. Charru, S. Hunt, P. Hopkins, R. Williams, J.M. Lalouel, and P. Corvol. 1992. Molecular basis of human hypertension: role of angiotensinogen. Cell. 71:169-180.
8. Caulfield, M., P. Lavender, M. Farrall, P. Munroe, M. Lawson, P. Turner, and A. Clark. 1994. Linkage of the angiotensinogen gene to essential hypertension. N. Engl. J. Med. 330:1629-1633.
9. Ward, K., A. Hata, X. Jeunemaitre, C. Helin, L. Nelson, C. Namikawa, P. Farrington, M. Ogasawara, K. Suzumori, S. Tomoda, et al. 1993. A molecular variant of angiotensinogen associated with preeclampsia. Nat. Genet. 4:59-61.
10. Caulfield, M., P. Lavender, J. Newell-Price, M. Farrall, S. Kamdar, H. Daniel, M. Lawson, P. De Freitas, P. Fogarty, and A. Clark. 1995. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J. Clin. Invest. 96:687-692.
11. Bonnardeaux, A., E. Davies, X. Jeunemaitre, I. Fery, A. Charru, E. Clauser, L. Tiret, F. Cambien, P. Corvol, and F. Soubrier. 1994. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension. Dallas. 24:63-69.
12. Cambien, F., O. Poirier, L. Lecerf, A. Evans, J. Cambou, D. Arveiler, G. Luc, J. Bard, L. Bara, S. Ricard, et al. 1992. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature (Lond.). 359:641-644.
13. Katsuya, T., G. Koike, T.W. Yee, N. Sharpe, R. Jackson, R. Norton, M. Horiuchi, R. Pratt, V. Dzau, and S. MacMahon. 1995. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet. 345:1600-1603.
14. Schunkert, H., H. Hense, S. Holmer, M. Slender, S. Perz, U. Keil, B. Lorell, and G. Riegger. 1994. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N. Engl. J. Med. 330:1634-1638.
15. Marre, M., P. Bernadet, Y. Gallois, F. Savagner, T. Guyene, M. Hallab, F. Cambien, P. Passa, and F. Alhenc-Gelas. 1994. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes. 43:384-388.
16. Doria, A., J. Warram, and A. Krolewski. 1994. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes. 43:690-695.
17. Harden, P., C. Geddes, P. Rowe, J. McIlroy, M. Boulton-Jones, S. Rodger, B. Junor, J. Briggs, J. Connell, and A. Jardine. 1995. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet. 345:1540-1542.
18. Hunley, T., B. Julian, J. Phillips III, M. Summar, H. Yoshida, R. Horn, N. Brown, A. Fogo, I. Ichikawa, and V. Kon. 1996. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int. 49:571-577.
19. Yoshida, H., T. Mitarai, T. Kawamura, T. Kitajima, Y. Miyazaki, R. Nagasawa, Y. Kawaguchi, H. Kubo, I. Ichikawa, and O. Sakai. 1995. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J. Clin. Invest. 96: 2162-2169.
20. Yorioka, T., T. Suehiro, N. Yasuoka, and M. Kawada. 1995. Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy. Clin. Nephrol. 44:80-85.
21. Lindpaintner, K., M. Pfeffer, R. Kreutz, M. Stampfer, F. Grodstein, F. LaMotte, J. Buring, and C. Hennekens. 1995. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. Med. 332:706-711.
22. Lindpaintner, K., M. Lee, M. Larson, V. Rao, M. Pfeffer, J. Ordovas, E. Schaefer, A. Wilson, P. Wilson, R. Vasan, et al. 1996. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N. Engl. J. Med. 334:1023-1028.
23. Schmidt, S., E. Stier, R. Hartung, G. Stein, J. Bahnisch, A.J. Woodroffe, A.R. Clarkson, C. Ponticelli, M. Campise, G. Mayer, D. Ganten, and E. Ritz. 1995. No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am. J. Kidney Dis. 26:727-731.
24. Schimidt, S., N. Schone, E. Ritz, and The Diabetic Nephropathy Study Group. 1995. Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int. 47:1176-1181.
25. Pei, Y., D. Cattran, and C. Greenwood. 1992. Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int. 42:960-966.
26. Levey, A., M. Madalo, and R. Perrone. 1991. Laboratory assessment of renal disease: clearance, urinalysis, and renal biopsy. In The Kidney. 4th ed. B. Brenner and F. Rector, editors. W.B. Saunders Co., Philadelphia. 925-929.
27. Miller, S., D. Dykes, and G. Polesky. 1988. Simple salting-out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res. 16:1215.
28. 235→Thr allele of the human angiotensinogen gene. Hum. Mol. Genet. 2:609-610.
29. Rigat, B., C. Hubert, P. Corvol, and F. Soubrier. 1992. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (dipeptidyl carboxypeptidase 1). Nucl. Acids Res. 20:1433.
30. Fogarty, D., A. Maxwell, C. Doherty, A. Hughes, and N. Nevin. 1994. ACE gene typing. Lancet. 343:851.
31. 1 gene. Hum. Mol. Genet. 3:1444.
32. Hosmer, D., and S. Lemeshow. 1989. Applied Logistic Regression. J. Wiley and Sons, New York.
33. Weissman, S. 1995. Genetic bases for common polygenic diseases. Proc. Natl. Acad. Sci. USA. 92:8543-8544.
34. Lifton, R. 1995. Genetic determinants of human hypertension. Proc. Natl. Acad. Sci. USA. 92:8545-8551.
35. Kim, H.S., J. Krege, K. Kluckman, J. Hagaman, J. Hodgin, C. Best, C. Jennette, T. Coffman, N. Maeda, and O. Smithies. 1995. Genetic control of blood pressure and the angiotensinogen. Proc. Natl. Acad. Sci. USA. 92:2735-2739.
36. Forgarty, D., C. Harron, A. Hughes, N. Nevin, C. Doherty, and P. Maxwell. 1996. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes. 45:1204-1208.
37. Burns, D., T. Homma, and R. Harris. 1993. The intra-renal renin-angiotensin system. Sem. Nephrol. 13:13-30.
38. Kagami, S., W. Border, D. Miller, and N. Noble. 1994. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J. Clin. Invest. 93:2431-2437.
39. Lafayette, R., G. Mayer, S. Park, and T. Meyer. 1992. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J. Clin. Invest. 90:766-771.
40. Lee, L., T. Meyer, A. Pollock, and D. Lovett. 1995. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J. Clin. Invest. 96: 953-964.
41. Lander, E., and L. Kruglyak. 1995. Genetic dissection of complex traits: Guidelines for the interpretation and reporting of linkage results. Nat. Genet. 11:241-247.
42. Bell, J., and M. Lathrop. 1996. Multiple loci for multiple sclerosis. Nat. Genet. 13:377-378.